SG163571A1 - Rotavirus vaccine inducing heterotypic cross protection - Google Patents

Rotavirus vaccine inducing heterotypic cross protection

Info

Publication number
SG163571A1
SG163571A1 SG201004843-7A SG2010048437A SG163571A1 SG 163571 A1 SG163571 A1 SG 163571A1 SG 2010048437 A SG2010048437 A SG 2010048437A SG 163571 A1 SG163571 A1 SG 163571A1
Authority
SG
Singapore
Prior art keywords
cross protection
rotavirus vaccine
vaccine inducing
heterotypic cross
inducing
Prior art date
Application number
SG201004843-7A
Other languages
English (en)
Inventor
Brigitte Desiree Alberte Colau
Vos Beatrice Arsene Virginie De
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0516944A external-priority patent/GB0516944D0/en
Priority claimed from GB0521164A external-priority patent/GB0521164D0/en
Priority claimed from GB0608962A external-priority patent/GB0608962D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of SG163571A1 publication Critical patent/SG163571A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG201004843-7A 2005-08-17 2006-08-15 Rotavirus vaccine inducing heterotypic cross protection SG163571A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0516944A GB0516944D0 (en) 2005-08-17 2005-08-17 Vaccine
GB0521164A GB0521164D0 (en) 2005-10-18 2005-10-18 Vaccine
GB0608962A GB0608962D0 (en) 2006-05-05 2006-05-05 Vaccine

Publications (1)

Publication Number Publication Date
SG163571A1 true SG163571A1 (en) 2010-08-30

Family

ID=37757924

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201004843-7A SG163571A1 (en) 2005-08-17 2006-08-15 Rotavirus vaccine inducing heterotypic cross protection

Country Status (25)

Country Link
US (1) US20090028828A1 (el)
EP (2) EP2233153B1 (el)
JP (1) JP5519934B2 (el)
KR (1) KR20080036648A (el)
AR (1) AR054916A1 (el)
AU (1) AU2006281566B2 (el)
BR (1) BRPI0615203A2 (el)
CA (1) CA2619751C (el)
CR (1) CR9759A (el)
CY (1) CY1116135T1 (el)
DK (1) DK2233153T3 (el)
EA (1) EA014328B1 (el)
ES (1) ES2534637T3 (el)
HR (1) HRP20150310T1 (el)
IL (1) IL189289A0 (el)
MA (1) MA29700B1 (el)
MX (1) MX2008002270A (el)
NO (1) NO20080754L (el)
PE (1) PE20070235A1 (el)
PL (1) PL2233153T3 (el)
PT (1) PT2233153E (el)
SG (1) SG163571A1 (el)
SI (1) SI2233153T1 (el)
TW (1) TW200740457A (el)
WO (1) WO2007020078A2 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107510D0 (en) 2001-03-26 2001-05-16 Univ Bristol New elongase gene and a process for the production of -9-polyunsaturated fatty acids
WO2009042202A2 (en) 2007-09-25 2009-04-02 Aridis Pharmaceuticals Formulations for preservation of rota virus
US9311112B2 (en) * 2009-03-16 2016-04-12 Apple Inc. Event recognition
BR112013027457A2 (pt) * 2011-04-28 2019-09-24 Int Medica Foundation preparação de vacina, e, métodos de fabricar uma preparação de vacina, e de vacinar um mamífero
CN110227152A (zh) * 2012-04-23 2019-09-13 巴拉特生物技术国际有限公司 轮状病毒疫苗组合物及其制备方法
WO2017062246A1 (en) 2015-10-05 2017-04-13 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human rota virus g9p[6] strain and use as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69130068T2 (de) * 1990-11-16 1999-01-07 Children's Hospital Medical Center, Cincinnati, Ohio Humane rotativen, impfstoffe und methoden
UA77388C2 (uk) * 1999-08-17 2006-12-15 Глаксосмітклайн Байолоджікалз С.А. Послаблена популяція ротавірусів людини, ротавірус та вакцинна композиція, що містить живий послаблений ротавірус людини
EP1660123B1 (en) * 2003-09-02 2013-03-13 GlaxoSmithKline Biologicals s.a. Rotavirus vaccine

Also Published As

Publication number Publication date
CY1116135T1 (el) 2017-02-08
WO2007020078A3 (en) 2007-05-24
PE20070235A1 (es) 2007-04-04
KR20080036648A (ko) 2008-04-28
MX2008002270A (es) 2008-03-27
CA2619751A1 (en) 2007-02-22
EP1915173A2 (en) 2008-04-30
TW200740457A (en) 2007-11-01
DK2233153T3 (da) 2015-04-27
AU2006281566B2 (en) 2011-09-01
AU2006281566A1 (en) 2007-02-22
AR054916A1 (es) 2007-07-25
EA014328B1 (ru) 2010-10-29
IL189289A0 (en) 2008-06-05
JP2009504701A (ja) 2009-02-05
US20090028828A1 (en) 2009-01-29
PL2233153T3 (pl) 2015-06-30
EP2233153B1 (en) 2015-01-21
BRPI0615203A2 (pt) 2011-05-10
CR9759A (es) 2008-05-05
SI2233153T1 (sl) 2015-05-29
PT2233153E (pt) 2015-04-20
ES2534637T3 (es) 2015-04-27
HRP20150310T1 (hr) 2015-06-19
NO20080754L (no) 2008-05-15
MA29700B1 (fr) 2008-08-01
WO2007020078A2 (en) 2007-02-22
JP5519934B2 (ja) 2014-06-11
EA200800320A1 (ru) 2008-10-30
CA2619751C (en) 2016-07-05
EP2233153A1 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
MX2022010008A (es) Composiciones inmunogenicas de coronavirus y usos de las mismas.
SG163571A1 (en) Rotavirus vaccine inducing heterotypic cross protection
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
EP2491947A3 (en) Vaccine
WO2002009643A3 (en) Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
MX2009003325A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua.
EP1504112A4 (en) DEVELOPMENT OF A VACCINE FOR THE PREVENTION OF INFECTIONS WITH THE FILOVIRUS IN PRIMATES
IN2012DN00829A (el)
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
NO20073900L (no) Anvendelse av LGG for fremstilling av et medikament for forebygging eller behandling av respiratoriske sykdommer
WO2011019932A3 (en) Compositions and methods for the therapy and diagnosis of influenza
MD20100029A2 (ro) Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) şi vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
UA99719C2 (ru) Вакцина для собак против болезни лайма
UA91694C2 (ru) Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций
EA201071412A1 (ru) Дронедарон для предотвращения кардиоверсии
MX2010003591A (es) Capa protectora mecanica para formas de dosificacion solidas.
DK1476467T3 (da) IgG3-immunglobulin som beskyttelsesmarkör mod virusinfektionssygdomme og anvendelser deraf
WO2008037753A3 (de) Elastische provisorische suprakonstruktion für ein dentales implantat
WO2010080188A3 (en) Epitope targeted anthrax vaccine
WO2011084967A3 (en) Methods and compositions for providing protective immunity in the elderly
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
WO2009077744A3 (en) Vaccines for brucellosis
ZA202104747B (en) Novel trypanosomal vaccine
DE602005012401D1 (en) Alpha-defensine als anthrax-immuntherapeutika